Last reviewed · How we verify

NCT05822349

Effect of Using Pictograms on Improving Depression and Anxiety Among Type 2 Diabetic Patients.

Status unknown NA Last updated 20 April 2023
What this trial tests

NA trial testing picograms-enriched label in Type 2 Diabetes in 204 participants. Status unknown.

Timeline
1 April 2023
Primary endpoint
1 July 2023
1 August 2023

Quick facts

Lead sponsorUniversity of Jordan
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment204
Start date1 April 2023
Primary completion1 July 2023
Estimated completion1 August 2023
Sites1 location across Jordan

Drugs / interventions tested

Conditions studied

Sponsor

University of Jordan

Who can join

18 and older, any sex, with Type 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

we will study the impact of using pictograms on improving depression and anxiety among type 2 diabetic patients, we suppose that patients who received pictograms-enriched labels will have lower levels of depression and anxiety in comparison with those who will not receive after three month follow-up evaluation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Type 2 Diabetes

Currently open trials in the same condition.

Other University of Jordan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05822349.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing